Real-time enrollment status for this primary immunoglobulin a nephropathy (igan) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:14 PM UTC
| NCT Number | NCT06994845 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunoglobulin A Nephropathy (IgAN) |
| Phase | Clinical Trial |
| Target Enrollment | 31 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 1, 2026 (Jun 1, 2026) |
As of July 13, 2026: Clinical trial NCT06994845 is currently recruiting participants. This clinical trial study for primary immunoglobulin a nephropathy (igan) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06994845 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06994845 was last updated Jun 1, 2026 (June 1, 2026). HelloStudys verifies this status automatically.